1
|
Chatterjee S, Basak P, Tan S, Lefort S, Pellacani D, Safneck J, Buchel E, Aparicio S, Eaves CJ, Raouf A. Abstract P5-07-04: Not presented. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-07-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was not presented at the conference.
Citation Format: Chatterjee S, Basak P, Tan S, Lefort S, Pellacani D, Safneck J, Buchel E, Aparicio S, Eaves CJ, Raouf A. Not presented [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-07-04.
Collapse
Affiliation(s)
- S Chatterjee
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - P Basak
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - S Tan
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - S Lefort
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - D Pellacani
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - J Safneck
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - E Buchel
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - S Aparicio
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - CJ Eaves
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| | - A Raouf
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Section of Plastic Surgery, Faculty of Health Sciences University of Manitoba, Winnipeg, MB, Canada
| |
Collapse
|
2
|
Chatterjee S, Berdnikov A, Buchel E, Safneck J, Marshall AJ, Murphy LC, Raouf A. Abstract P5-07-02: Not presented. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-07-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was not presented at the conference.
Citation Format: Chatterjee S, Berdnikov A, Buchel E, Safneck J, Marshall AJ, Murphy LC, Raouf A. Not presented [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-07-02.
Collapse
Affiliation(s)
- S Chatterjee
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - A Berdnikov
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - E Buchel
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - J Safneck
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - AJ Marshall
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - LC Murphy
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| | - A Raouf
- Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB, Canada; Section of Plastic Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
| |
Collapse
|
3
|
Chatterjee S, Berdnikov A, Lee-Wing V, Safneck J, Buchel E, Raouf A. Abstract P4-03-11: Fibroblasts isolated from the “normal-like” tissue adjacent to breast tumours suppress healthy epithelial progenitor cell proliferation while supporting tumour cell growth. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p4-03-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The tissue adjacent to breast tumors has been referred to as “normal-like” tissue despite exhibiting many alterations at epigenetic and gene expression levels consistent with enhanced proliferation and wound healing signatures. However, the influence of such alterations on the proliferation and differentiation of healthy breast progenitors is currently unknown. Fibroblasts are a major component of microenvironment for the healthy and malignant breast cells. We therefore, isolate fibroblast from primary breast tumors, tissue adjacent to tumors (TAT) and the healthy breast tissue and examine their ability to support proliferation of healthy and malignant breast cells. To characterize the TAT samples we first utilized clonal co-culture assays using breast cells obtained from the healthy breast tissue (reduction mammoplasty sample, RM) and the healthy fibroblasts. Our results suggested that the TAT samples surprisingly contained significantly decreased pool of progenitors compared to the RM samples. In order to study the underlying mechanism, we characterized fibroblasts derived from either the breast tumours (TAFs) or the TAT samples (TATF) or the RM normal samples (NAFs) and assessed their role on breast progenitor cell functions. Fibroblasts were isolated from the ER+ and ER- breast tumours and their adjacent breast tissue. We observed that matrigel co-cultures consisting of RM samples and NAFs led to a 5.5-fold expansion of the progenitors, whereas the co-cultures of TAT or the RM samples with either TAFs or TATFs failed to show expansion of epithelial progenitors. The comparative secretome analysis of the NAFs and the TATFs identified TGFβ as a candidate molecule primarily secreted only by the TATFs and not by NAFs. Interestingly, blocking TGFβ signaling restored both TAFs' and TATFs' ability to support the expansion of healthy progenitors in matrigel cultures. Lastly, we found that TAFs were able to enhanced breast cancer cell proliferation in vivo and in vitro but to a lesser extent than the TAFs. Our observations suggest that the tissues adjacent to breast tumours are transformed into a TGFβ-enriched environment that is supportive of breast tumour growth while suppressing the proliferation and differentiation potentials of the healthy breast progenitors. Our data also suggest that the use of TGFβ blockers may be important in reducing risk of local breast tumour recurrence.
Citation Format: Chatterjee S, Berdnikov A, Lee-Wing V, Safneck J, Buchel E, Raouf A. Fibroblasts isolated from the “normal-like” tissue adjacent to breast tumours suppress healthy epithelial progenitor cell proliferation while supporting tumour cell growth [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P4-03-11.
Collapse
Affiliation(s)
- S Chatterjee
- Research Institute in Oncology and Hematology, Winnipeg, MB, Canada; University of Manitoba, Winnipeg, MB, Canada
| | - A Berdnikov
- Research Institute in Oncology and Hematology, Winnipeg, MB, Canada; University of Manitoba, Winnipeg, MB, Canada
| | - V Lee-Wing
- Research Institute in Oncology and Hematology, Winnipeg, MB, Canada; University of Manitoba, Winnipeg, MB, Canada
| | - J Safneck
- Research Institute in Oncology and Hematology, Winnipeg, MB, Canada; University of Manitoba, Winnipeg, MB, Canada
| | - E Buchel
- Research Institute in Oncology and Hematology, Winnipeg, MB, Canada; University of Manitoba, Winnipeg, MB, Canada
| | - A Raouf
- Research Institute in Oncology and Hematology, Winnipeg, MB, Canada; University of Manitoba, Winnipeg, MB, Canada
| |
Collapse
|
4
|
Long R, Guzman R, Greenberg H, Safneck J, Hershfield E. Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest 1999; 115:522-31. [PMID: 10027455 DOI: 10.1378/chest.115.2.522] [Citation(s) in RCA: 191] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
To define the epidemiology, pathogenesis, pathology, presentation, and management of tuberculous mycotic aneurysm of the aorta (TBAA) in the therapeutic era, we reviewed all of the cases reported in the English language literature from 1945 to the present. To the 39 cases in the published literature, we add two cases of our own. Although it is exceedingly rare, the prevalence of this lesion has remained relatively constant. In 75% of the cases, TBAA appeared to result from erosion of the aortic wall by a contiguous focus; 25% from direct seeding of the aortic intima or of the adventitia or media (via the vasa vasorum). Most of the aneurysms were saccular (90%) and false (88%). The thoracic and abdominal aortas were affected with equal frequency. The mean (+/- SD) age of the patients was 50+/-16 years. Twenty-two were men, and 19 were women. In 63% of the cases, tuberculosis (TB) was diagnosed at presentation. Disseminated TB was present in 46% of the cases. One or more of three clinical scenarios suggested TBAA: persistent pain, major bleeding, and a palpable or radiographically visible para-aortic mass, especially if it is expanding or pulsatile. In turn, each of these findings suggested a complication of TBAA that may be an indication for surgical intervention. Among the patients who were offered both medical and surgical treatment, 20 of 23 (87%) survived. Among those who were offered only one form of treatment or were offered no treatment at all there were no survivors. Both in situ reconstruction with a prosthetic graft, and extra-anatomic bypass appeared to offer excellent results, provided that an effective regimen of antituberculous drugs was delivered postoperatively. We offer our conclusions: (1) symptomatic TBAA is a rare but uniformly fatal lesion if not diagnosed promptly, (2) in the context of active TB, and especially miliary TB, TBAA should be suspected whenever one or more of the three clinical scenarios are present, and (3) combined medical and surgical therapy appears to offer the best chance of a cure.
Collapse
Affiliation(s)
- R Long
- Department of Medicine, University of Manitoba, Winnipeg, Canada
| | | | | | | | | |
Collapse
|